Dec 31, 2016

ANI Pharmaceuticals Q4 2016 Earnings Report

Total Revenue
$38.2M
Previous year: $18M
+111.8%
EPS
$0.84
Previous year: $0.52
+61.5%
Gross Profit
$21.3M
Previous year: $14.5M
+46.9%
Cash and Equivalents
$27.4M
Previous year: $155M
-82.3%
Free Cash Flow
$10.7M
Previous year: $3.6M
+197.3%
Total Assets
$323M
Previous year: $285M
+13.2%

ANI Pharmaceuticals

ANI Pharmaceuticals